Eradication rate and safety of vonoprazan-amoxicillin dual therapy for helicobacter pylori eradication: a randomized controlled trial
Vonoprazan-amoxicillin dual therapy demonstrates superior eradication efficacy and reduced adverse events compared to quadruple therapy in <i>H. pylori</i>-infected patients, suggesting its potential for clinical application and promotion.
Authors
- Guo‐Ping Jiang (ORCID: https://orcid.org/0000-0001-9448-0989)
- Mengzhao Luo
- Feng Zhou (ORCID: https://orcid.org/0000-0002-1735-7204)
- Yanqun Cong
- Pei-Fen Zheng
- Yuliang Feng (ORCID: https://orcid.org/0009-0002-9227-9717)
Institutions
- Zhejiang Hospital (CN)
Publication Details
- Journal
- Scandinavian Journal of Gastroenterology
- Published
- 2024-09-22
- DOI
- https://doi.org/10.1080/00365521.2024.2407898
- Citations
- 8
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 4.58
Funders
- Medical Science and Technology Project of Zhejiang Province